Fiji vs Oman: New cases tested for RR-/MDR-TB
Fiji
100.0%
in 2024
Oman
100.0%
in 2024
Fiji rank
1st
Oman rank
1st
New cases tested for RR-/MDR-TB over time
- Fiji
- Oman
How they compare
Fiji currently reports 100.0% against 100.0% in Oman, a difference of 0.0%.
The two have swapped places 4 times across 18 shared years of data; in 2006 it was Oman ahead.
Fiji ranks 1st and Oman ranks 1st of 192 countries.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Fiji | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.8% | 74.0% | 53.2% | Oman |
| 2010s | 48.0% | 95.9% | 47.9% | Oman |
| 2020s | 79.2% | 91.2% | 12.0% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Fiji or Oman?
- Fiji, at 100.0% against 100.0% in Oman as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Fiji and Oman?
- 0.0%, with Fiji ahead.
- How many years of comparable data are there for Fiji and Oman?
- 18 years are reported by both, from 2006 to 2024.
- How do Fiji and Oman rank globally for new cases tested for rr-/mdr-tb?
- Fiji ranks 1st and Oman ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.